A Comparison of the Tumor Response in Esophageal Cancer Patients Treated with Tri-modality Approach Using Either Cisplatin/5-FU or Carboplatin/Paclitaxel and Concomitant Radiation Therapy

Authors :: W. Hopman
Conrad Falkson
W. Chung
N. Moideen
Aamer Mahmud
D. Hurlbut
James Joseph Biagi
Source :: International Journal of Radiation Oncology*Biology*Physics. 105:E192
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
Cisplatin
Cancer Research
medicine.medical_specialty
Radiation
Modality (human–computer interaction)
business.industry
medicine.medical_treatment
Esophageal cancer
Tumor response
medicine.disease
Carboplatin/paclitaxel
Radiation therapy
Internal medicine
Concomitant
medicine
Radiology, Nuclear Medicine and imaging
business
medicine.drug

Full Text Access

Tools